Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Hwang, Clara
Henderson, Nicholas
Cackowski, Frank Cameron
Pilling, Amanda
Jang, Albert
Rothstein, Shoshana
Labriola, Matthew
Park, Joseph J.
Ghose, Alyssa
Bilen, Mehmet Asim
Kilari, Deepak
Tripathi, Abhishek
Garje, Rohan
Koshkin, Vadim S.
Schweizer, Michael Thomas
Armstrong, Andrew J.
Mckay, Rana R.
Dorff, Tanya B.
Alva, Ajjai Shivaram
Barata, Pedro C.
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Univ Michigan, Dept Biostat, Ann Arbor, MI USA
[3] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[4] Tulane Univ, Sch Med, New Orleans, LA USA
[5] Duke Univ, Div Med Oncol, Durham, NC USA
[6] Univ Michigan, Dept Med, Div Hematol & Oncol, Ann Arbor, MI USA
[7] Univ Michigan, Ann Arbor, MI USA
[8] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[9] Med Coll Wisconsin, Froedtert Canc Ctr, Dept Med, Milwaukee, WI USA
[10] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA
[11] Univ Iowa, Div Hematol Oncol, Dept Internal Med, Iowa City, IA USA
[12] Univ Calif San Francisco, San Francisco, CA USA
[13] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[14] Duke Univ, Sch Med, Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC USA
[15] Univ Calif San Diego Hlth, La Jolla, CA USA
[16] City Hope Comprehens Canc Ctr, Duarte, CA USA
[17] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[18] Tulane Univ, Sch Med, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5013
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Modulation of plasma lipidomic signature in metastatic castration-resistant prostate cancer (mCRPC).
    Mak, Blossom
    Mahon, Kate Lynette
    Stockler, Martin R.
    Joshua, Anthony M.
    Zhang, Alison Yan
    Parnis, Francis
    Meikle, Peter
    Horvath, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [32] Biomarker analysis from a randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC).
    McKay, Rana R.
    Radke, Marc R.
    Shyr, Yu
    Zhao Shilin
    Taplin, Mary-Ellen
    Davis, Nancy B.
    Monk, Paul
    Appleman, Leonard Joseph
    Lara, Primo Lucky N.
    Vaishampayan, Ulka N.
    Zhang Jingsong
    Paul, Asit K.
    Bubley, Glenn
    Huang Ying
    Shapiro, Geoffrey
    LoRusso, Patricia
    Ivy, Percy S.
    Petrylak, Daniel Peter
    Swisher, Elizabeth M.
    Kim, Joseph W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [33] Biomarker Analysis of Men With Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer Treated With Pembrolizumab
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 15 - 16
  • [34] Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)
    Sonpavde, Guru
    Wang, Christopher G.
    Galsky, Matthew D.
    Oh, William K.
    Armstrong, Andrew J.
    BJU INTERNATIONAL, 2015, 116 (01) : 17 - 29
  • [35] Phase II Study with metastatic castration-resistant Prostate Cancer (mCRPC) Patients
    Rexer, H.
    Graefen, M.
    UROLOGE, 2017, 56 (11): : 1468 - 1470
  • [36] INTERMITTENT (RECHALLENGE) CHEMOTHERAPY WITH DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Bracarda, Sergio
    Rossi, Marta
    Hamzaj, Alketa
    De Angelis, Verena
    De Simone, Valeria
    Caserta, Claudia
    Crino, Lucio
    ANNALS OF ONCOLOGY, 2009, 20
  • [37] Sarcopenia assessment in men with metastatic castration-resistant prostate cancer (mCRPC) undergoing radium 223 (Ra223) therapy
    Khan, M.
    Carvajal, J. Briones
    Parshad, S.
    Emmenegger, U.
    ANNALS OF ONCOLOGY, 2020, 31 : S535 - S535
  • [38] Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer
    Barata, Pedro C.
    Assayag, Jonathan
    Li, Benjamin
    Siu, Gordon
    Niyazov, Alexander
    JAMA ONCOLOGY, 2024, 10 (07) : 975 - 977
  • [39] Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Nanus, David M.
    Giannakakou, Paraskevi
    George, Daniel J.
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] Circulating-free DNA (cfDNA) as biomarker of taxane resistance in metastatic castration-resistant prostate cancer (mCRPC)
    Francini, Edoardo
    Ou, Fang-Shu
    Rhoades, Justin
    Wolfe, Eric G.
    O'Connor, Edward
    Ha, Gavin
    Gregory, Gydush
    Kelleher, Kaitlin
    Bhatt, Rupal Satish
    Balk, Steven P.
    Sweeney, Christopher
    Adalsteinsson, Viktor
    Taplin, Mary-Ellen
    Choudhury, Atish Dipankar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345